Fig. 1From: Determinants of response to inhaled extrafine triple therapy in asthma: analyses of TRIMARAN and TRIGGERChange from baseline in pre-dose FEV1 at Week 26, adjusted least squares mean difference BDP/FF/G versus BDP/FF in patient sub-groups. *p < 0.05. FEV1 forced expiratory volume in 1 s, BDP beclometasone dipropionate, FF formoterol fumarate, G glycopyrronium, BMI body mass indexBack to article page